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Epithelial–mesenchymal transitions are essential for
normal embryonic development and for progression
of non-invasive tumor cells into malignant, metastatic
carcinomas. Twist, an important regulator of
morphogenesis in the embryo, has recently been
implicated in the onset of invasive behavior during
tumor progression.
Growing evidence demonstrates that many genes and
proteins known to play essential roles during
embryonic development are mutated or aberrantly
expressed in cancerous cells. Studies of the genetic
regulatory programs that control normal developmen-
tal processes can therefore provide essential insights
into how such programs are inappropriately reacti-
vated during tumorigenesis. One widely studied
developmental event that is also central to tumor pro-
gression is the epithelial–mesenchymal transition or
EMT [1,2] (Figure 1). Cells undergoing an EMT experi-
ence transient structural changes resulting in loss of
polarity and contact with neighboring cells and the
acquisition of motility [3]. During normal development,
EMTs are vital to the gastrulation movements that
reorganize embryonic germ layers, as well as to the
development of other migratory cell types, such as the
neural crest [4,5]. Importantly, many of the molecular
and phenotypic changes associated with cells under-
going developmental EMTs are also characteristic of
the most aggressive metastatic cancer cells [1]. 
Most cancer-related deaths are caused, not by the
primary tumor itself, but by subsequent metastases.
While metastasis has been the subject of intense
research for over a century, the molecular mechanisms
governing the progression from a primary tumor cell to
an invasive, malignant cell remain ill-defined. What is
clear is that metastasis proceeds via a series of interre-
lated steps, each of which can be rate-limiting. These
steps include: invasion; entry into systemic circulation
(‘intravasation’); movement from the circulatory system
into a new host tissue (‘extravasation’); and proliferation
and growth of the secondary tumor [6]. EMTs are a key
event in the invasion step.
Loss of E-cadherin expression is emerging as one
of the most common indicators of EMT onset. E-
cadherin is required for the formation of stable
adherens junctions and thus the maintenance of an
epithelial phenotype. Because disruption of E-
cadherin-mediated cell adhesion appears to be a
central event in the transition from non-invasive to
invasive carcinomas, several studies have focused on
identifying and characterizing transcriptional repres-
sors of E-cadherin expression in epithelial tumor cells.
Strikingly, the most prominent factors to arise from
these studies, including the related factors Slug and
Snail, and the δEF1 protein SIP1 [7–10], are best
known for their roles in early embryogenesis,
particularly during gastrulation and neural crest
development [11,12]. 
A recent report from Weinberg’s laboratory [13] has
added yet another developmental regulator to the list
of genes with a role in tumor progression. The authors
found that Twist — a basic-helix–loop–helix (bHLH)
protein known to be essential for proper gastrulation,
mesoderm formation and neural crest migration —
can also mediate EMTs during tumor progression.
Yang et al. [13] took advantage of four isogenic
tumor cell lines derived earlier from a single sponta-
neously arising mammary tumor in a wild-type BALB/c
mouse [14]. These cell lines display discrete differ-
ences in metastatic potential corresponding to
sequential steps in the metastatic pathway. The
authors injected cells from these lines into mouse
mammary fat pads and allowed them to develop into
primary tumors. Microarray analysis was used to iden-
tify genes that are differentially expressed in tumors
established from each of the cell lines. This analysis
identified a number of genes previously implicated in
metastasis. In the data set correlating gene expres-
sion with invasiveness and/or intravasation, Twist
stood out as one of the most strongly upregulated
genes. Given its established roles in embryonic mor-
phogenesis [15,16], Twist was an especially attractive
candidate for further investigation. 
Additional studies were performed using the most
fully metastatic of the cell lines, 4T1, to determine
when Twist is required during metastatic progression
[13]. Yang et al. [13] found that inhibition of Twist
expression — using small interfering (si)RNAs — is
sufficient to greatly diminish the metastatic potential
of the 4T1 cell line, without affecting its proliferative
capacity. Furthermore, the number of 4T1 cells
detected in the bloodstream was significantly reduced
following Twist inhibition. This suggested that Twist is
required either upstream of intravasation or for sur-
vival during anchorage-independent growth in the
blood. The latter possibility was ruled out by showing
that loss of Twist does not affect the ability of these
cells to form colonies in soft agar. 
The most likely role for Twist during metastatic
progression appears to be in the acquisition of inva-
sive properties. Yang et al. [13] showed that forced
Twist expression is sufficient to induce phenotypic
and molecular hallmarks of an EMT in MDCK cells and
in immortalized human mammary epithelial cells.
Moreover, endogenous Twist expression was found to
correlate with metastatic potential in a panel of human
epithelial tumor cell lines. 
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These findings are strikingly similar to what has
been shown previously for Slug, Snail and SIP1 [7–10].
Indeed, all of these factors, including Twist, have been
shown to down-regulate the activity of the E-cadherin
promoter in a manner that appears to be dependent
upon the presence of a series of inhibitory E-box sites
[7–10,13]. The three zinc-finger containing proteins,
Slug, Snail and SIP1, are hypothesized to bind the
promoter via these E-boxes and directly repress E-
cadherin transcription. The mechanism by which Twist
down-regulates E-cadherin expression is less clear.
Twist can bind to E-box sites as a homo-dimer, but it
is thought to function as a transcriptional activator in
this context [15]. 
Twist can also negatively influence the expression
of downstream genes, but generally does so by block-
ing the activity of positive regulators of these targets
via protein–protein interaction. Thus, Twist might
directly down-regulate E-cadherin expression by
binding to, and inhibiting, the activity of a positive
regulator of E-cadherin transcription. If this is the
case, however, it is unclear why Twist-mediated
downregulation of E-cadherin should be dependent
upon the inhibitory E-box sites in the promoter.
Beyond its effects on E-cadherin expression, Twist
could potentially activate the transcription of genes
characteristic of the mesenchymal state, such as
vimentin and fibronectin, and this may be a fruitful
area of future investigation. 
To what extent is Twist’s ability to mediate an EMT
dependent upon the other developmental regulatory
proteins implicated in this process? This is an impor-
tant question, as during mesoderm formation in
Drosophila, Twist plays a direct role in activating Snail
expression [15]. Twist also has Snail-independent
functions in Drosophila, however, as the Twist mutant
phenotype can only be partially rescued by Snail.
Moreover, Twist appears to function downstream, or
independent of, Snail and Slug during neural crest
development in vertebrates [11,16]. What then is the
relationship between Twist and Snail during tumor
metastasis? Yang et al. [13] were unable to detect
upregulation of Snail expression in cells undergoing an
EMT in response to Twist. However, the ability of Twist
to induce expression of either Slug or SIP1 was not
examined in this study. Future studies might profitably
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Figure 1. EMTs are a crucial step in both
tumor progression and normal
development.
(A) The four major steps of tumor metas-
tasis. An EMT is required for cells to
undergo the first step of metastasis,
invasion (1). Invasive tumor cells can then
enter into systemic circulation (2) before
extravasating (3) and establishing a sec-
ondary tumor in a new host environment
(4). (B) A cross-section through a gastru-
lating avian embryo. During gastrulation,
cells of the epiblast (blue cells) undergo
an EMT and migrate toward and through
the primitive streak (PS). (C) A cross-
section through a neurula stage verte-
brate embryo. Following neural tube (NT)
closure, multipotent neural crest cells
undergo an EMT, delaminate from the
dorsal aspect of the neural tube and
migrate extensively throughout the
embryo before giving rise to a diverse set
of derivatives that include much of the
peripheral nervous system, melanocytes
and most of the craniofacial skeleton.
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explore whether individual members of this group can
exert their effects independently of the others. 
While much of the aforementioned work was
performed using animal models or in cell culture, a
recent report has correlated Snail up-regulation with
invasive ductal carcinomas of the breast [17]. In the
new study [13], by contrast, the only statistically
significant correlation reported was between Twist
expression and a less prevalent form of breast cancer,
invasive lobular carcinoma. These findings are con-
sistent with a previous report [18] indicating that the
Twist promoter is more frequently methylated in
invasive ductal carcinomas than in invasive lobular
carcinomas. Identifying the basis of these different
relationships could yield important insight into the
development of various types of malignant breast
tumor. Moreover, as Twist, Snail and SIP1 have also
been linked to gastric cancers [19], these factors may
play important roles during the metastatic progression
of a wide range of carcinomas.
Although many unresolved questions remain, Yang
et al. [13] have firmly placed Twist onto a lengthening
list of developmental regulatory proteins capable of
mediating EMTs in tumor cells. This work adds to a
growing body of evidence that cancerous cells often
reactivate latent developmental programs in order to
efficiently execute multiple steps in tumorigenesis.
The parallels between genes implicated in tumor
progression and those controlling the development of
neural crest — a population of stem cell-like embry-
onic progenitor cells — are particularly striking. Neural
crest cells must undergo an EMT and migrate exten-
sively in a manner analogous to tumor cells before
ultimately giving rise to a diverse array of derivatives
characteristic of vertebrates [3,5]. Aberrant develop-
ment of neural crest cells is also linked to a variety of
human cancers including neuroblastoma [20]. Given
these ties, future studies on neural crest development,
and on the formation and development of epithelial
tumors, should continue to enhance and extend our
understanding of both processes.
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